| Literature DB >> 32587503 |
Krzysztof M Bernadzki1, Patrycja Daszczuk1, Katarzyna O Rojek1,2, Marcin Pęziński1, Marta Gawor1, Bhola S Pradhan1, Teresa de Cicco1, Monika Bijata3, Krystian Bijata3, Jakub Włodarczyk3, Tomasz J Prószyński1,4, Paweł Niewiadomski1,5.
Abstract
The neuromuscular junctions (NMJs) connect muscle fibers with motor neurons and enable the coordinated contraction of skeletal muscles. The dystrophin-associated glycoprotein complex (DGC) is an essential component of the postsynaptic machinery of the NMJ and is important for the maintenance of NMJ structural integrity. To identify novel proteins that are important for NMJ organization, we performed a mass spectrometry-based screen for interactors of α-dystrobrevin 1 (aDB1), one of the components of the DGC. The guanidine nucleotide exchange factor (GEF) Arhgef5 was found to be one of the aDB1 binding partners that is recruited to Tyr-713 in a phospho-dependent manner. We show here that Arhgef5 localizes to the NMJ and that its genetic depletion in the muscle causes the fragmentation of the synapses in conditional knockout mice. Arhgef5 loss in vivo is associated with a reduction in the levels of active GTP-bound RhoA and Cdc42 GTPases, highlighting the importance of actin dynamics regulation for the maintenance of NMJ integrity.Entities:
Keywords: Arhgef5; Rho GEFs; Rho-family GTPases; dystrophin-glycoprotein complex; muscle development; neuromuscular disease; neuromuscular junction
Year: 2020 PMID: 32587503 PMCID: PMC7299196 DOI: 10.3389/fnmol.2020.00104
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
FIGURE 1Arhgef5 binds to aDB1. (A) Lysates from C2C12 cells were incubated with beads coupled to either the unphosphorylated (713) or the phosphorylated (713-P) variant of aDB1 peptide containing the Y713 residue. Eluates from the beads were analyzed using mass spectrometry. Number of peptides from Grb2 and Arhgef5 identified in each eluate and percent peptide coverage of the full-length protein are shown. Data shown is a reanalysis of supplementary information from Gingras et al. (2016). (B) Domain architecture of Arhgef5 and its shorter C-terminal isoform TIM (only detected in humans). (C) FLAG-Arhgef5 C-terminal isoform was expressed in HEK293T cells and lysates were incubated with beads coupled to peptide 713 or 713-P. Eluates from the beads were analyzed by immunoblot. (D,E) FLAG-tagged Arhgef5 and GFP-tagged aDB1 were coexpressed in HEK293T cells, as indicated. (D) GFP-aDB1 was immunoprecipitated from the lysates using anti-GFP-coupled beads and eluates were analyzed by immunoblot. (E) FLAG-Arhgef5 was immunoprecipitated from the lysates using anti-FLAG- or rabbit IgG-coupled beads and eluates were analyzed by immunoblot.
FIGURE 2Arhgef5 localizes to AChR-rich regions of the NMJ. (A) Cryostat sections of TA muscle were analyzed by immunofluorescence. AChRs were detected using fluorescently labeled BTX. (B–D) TA muscle of P30 mice were electroporated with GFP-tagged Arhgef5 (B) or Arhgef5-C-term (C) or with GFP alone (D). After 14 days, the muscle was fixed and stained with fluorescently labeled BTX. Single fibers were isolated and imaged. Scale bars are 20 μm.
FIGURE 3Arhgef5 is not required for AChR cluster formation in cultured myotubes. (A) C2C12 myotubes were transfected with control siRNA or three different siRNAs targeting Arhgef5. Arhgef5 mRNA levels were measured by RT-qPCR in the transfected cells. (B) HEK293T cells were transfected with FLAG-Arhgef5 and either control siRNA or four different siRNAs against Arhgef5 (siRNA 1, 2, 3, 4). FLAG-Arhgef5 levels were measured by Western blot. (C–E) C2C12 cells were transfected with negative control (non-targeting) siRNA, Arhgef5 siRNA, or MuSK siRNA as positive control. Cells were stained with fluorescently labeled BTX to visualize AChR and actistain to visualize F-actin. No differences in total cluster number or complex pretzel-like cluster formation was observed upon Arhgef5 knockdown. As expected, knockdown of MuSK fully abrogates AChR cluster formation. Scale bar is 20 μm or 100 μm, as indicated. (F,G) C2C12 were transfected as in (C) and treated with soluble agrin for 72 h. Cells were fixed and stained with fluorescently labeled BTX to visualize AChR. Arhgef5 knockdown does not affect the abundance of AChR cluster in cells stimulated with agrin. Scale bars are 100 μm. See Supplementary Figure S1 for an image of sparse AChR clusters that form in the absence of agrin or laminin. ∗∗p < 0.01.
FIGURE 4Generation of muscle-specific Arhgef5 KO mice. (A) Strategy for the generation of conditional Arhgef5 knockouts. Mice with loxP sites flanking the third exon of Arhgef5 were crossed with Cre-recombinase expressing mice to produce knockout. (B) Genotyping shows successful recombination in the muscles but not tail tipss of AG5; Acta-Cre mice. (C) Quantification of Arhgef5 mRNA expression in AG5 and AG5; Acta-Cre mice at 50 and 500 days of age. Results are mean ± SEM of three mice from each genotype. (D) Proper alignment of pre- and post-synaptic elements in AG5; Acta-Cre muscles. Single fibers of tibialis anterior muscles isolated from AG5 and AG5; Acta-Cre mice were stained with BTX (to visualize AChR), fasciculin II (to visualize the synaptic cleft marker acetylcholinesterase), and anti-neurofilament + anti-synaptophysin antibodies (to visualize the presynaptic nerve terminal). Scale bar is 20 μm. ∗p < 0.05, ∗∗p < 0.01.
FIGURE 5Muscle-specific loss of Arhgef5 results in progressive loss of NMJ integrity (A). Classification of NMJs according to their fragmentation. Representative examples of NMJs from each class are shown (B,C). Relative percentages of NMJs belonging to each of the three classes in tibialis anterior muscles of AG5 and AG5; Acta-Cre mice at 50 and 500 days of age. Results are mean ± SEM of three mice from each genotype. At least 30 synapses were counted for each mouse. Arhgef5 muscle-specific knocdown causes increased fragmentation of NMJs at both ages (D). Visualization of the automated quantification of endplate and AChR areas of NMJs. The algorithm takes a maximum projection fluorescence image (top panel) and performs the segmentation of the image to calculate the AChR area (middle panel) or the total area of the endplate (bottom panel). Perforations area is calculated as the difference between endplate area and AChR area. (E) Neither the total endplate area nor the AChR area nor the perforations area were significantly different in tibialis anterior muscles of 500-day old AG5; Acta-Cre mice compared to AG5. Results are mean ± SEM. (F) Representative cross-sections of TA muscle of AG5 and AG5; Acta-Cre mice. F-actin was stained with Actistain and nuclei were stained with DAPI. Centralized nuclei are indicated with arrows. (G) Quantification of centralized nuclei per TA muscle cross-section for n = 3 mice per genotype. Results are mean ± SEM. (H) Quantification of fiber diameters in TA muscle cross-sections (samples as in G). Results are mean ± SEM. ∗p < 0.05.
FIGURE 6Active forms of Cdc42 and RhoA are reduced by muscle-specific Arhgef5 knockdown. (A,B) Active GTP-bound forms of Cdc42 (A) and RhoA (B) were precipitated from TA homogenates (upper panels) and Cdc42 and RhoA proteins were detected by Western blot from precipitates and tissue lysates (total). GAPDH was used as a loading control.